Genomic imbalances are involved in miR-30c and let-7a deregulation in ovarian tumors: implications for HMGA2 expression
- PMID: 28423547
- PMCID: PMC5400605
- DOI: 10.18632/oncotarget.15795
Genomic imbalances are involved in miR-30c and let-7a deregulation in ovarian tumors: implications for HMGA2 expression
Abstract
The High-mobility group AT-hook 2 protein (HMGA2) is involved in different processes during tumorigenesis. High expression levels of HMGA2 are found in various types of cancer, with recent studies highlighting the important role of miRNAs in the regulation of HMGA2 expression. We report a study of 155 ovarian tumors (30 sex-cord stromal tumors, 22 borderline tumors, and 103 carcinomas) analyzed for HMGA2 expression as well as the expression of two miRNAs targeting this gene, let-7a and miR-30c. We also evaluated the expression of the fragile histidine triad (FHIT) and lin28 homologues (LIN28A/B) genes which are known to be an enhancer of miR-30c expression and a repressor of let-7a, respectively. HMGA2 was found expressed at high levels in most samples analyzed, with clear cell carcinomas as the only exception. let-7a and miR-30c were highly deregulated in all tumor types. LIN28A and FHIT were found overexpressed in all examined tumor types. The chromosomal imbalances that might lead to loss of the genes expressing let-7a and miR-30c could be evaluated on the basis of previously generated karyotypic and high resolution comparative genomic hybridization (CGH) data on 103 tumors. 76% of the samples with an imbalanced genome had at least one chromosomal aberration leading to a deletion of a miRNA cluster for let-7a and miR-30c. FISH using locus specific probes for these clusters validate the aberrations at the gene level. Our study shows that genomic imbalances are involved in miR-30c and let-7a deregulation. One can reasonably assume that dysregulation of these miRNAs is a cause leading to HMGA2 upregulation in ovarian tumors.
Keywords: FHIT; HMGA2; LIN28A; let-7a; miR-30c.
Conflict of interest statement
The authors declare no competing financial interests.
Figures


Similar articles
-
Expressions of miR-30c and let-7a are inversely correlated with HMGA2 expression in squamous cell carcinoma of the vulva.Oncotarget. 2016 Dec 20;7(51):85058-85062. doi: 10.18632/oncotarget.13187. Oncotarget. 2016. PMID: 27835588 Free PMC article.
-
LncRNA ANRIL affects the sensitivity of ovarian cancer to cisplatin via regulation of let-7a/HMGA2 axis.Biosci Rep. 2019 Jul 5;39(7):BSR20182101. doi: 10.1042/BSR20182101. Print 2019 Jul 31. Biosci Rep. 2019. Retraction in: Biosci Rep. 2024 Jul 31;44(7):BSR-2018-2101_RET. doi: 10.1042/BSR-2018-2101_RET. PMID: 31189742 Free PMC article. Retracted.
-
HMGA1 and HMGA2 expression and comparative analyses of HMGA2, Lin28 and let-7 miRNAs in oral squamous cell carcinoma.BMC Cancer. 2014 Sep 23;14:694. doi: 10.1186/1471-2407-14-694. BMC Cancer. 2014. PMID: 25245141 Free PMC article.
-
Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy.Surg Oncol. 2016 Dec;25(4):429-434. doi: 10.1016/j.suronc.2016.05.016. Epub 2016 May 27. Surg Oncol. 2016. PMID: 27262492
-
HMGA2 and high-grade serous ovarian carcinoma.J Mol Med (Berl). 2013 Oct;91(10):1155-65. doi: 10.1007/s00109-013-1055-8. Epub 2013 May 19. J Mol Med (Berl). 2013. PMID: 23686260 Review.
Cited by
-
Molecular characterization of carcinosarcomas arising in the uterus and ovaries.Oncotarget. 2019 Jun 4;10(38):3614-3624. doi: 10.18632/oncotarget.26942. eCollection 2019 Jun 4. Oncotarget. 2019. PMID: 31217897 Free PMC article.
-
The microRNA miR-192/215 family is upregulated in mucinous ovarian carcinomas.Sci Rep. 2018 Jul 23;8(1):11069. doi: 10.1038/s41598-018-29332-7. Sci Rep. 2018. PMID: 30038317 Free PMC article.
-
miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.J Exp Clin Cancer Res. 2018 Feb 1;37(1):19. doi: 10.1186/s13046-018-0686-6. J Exp Clin Cancer Res. 2018. PMID: 29391048 Free PMC article.
-
miR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt/β-catenin signaling and autophagy via targeting HMGA2.Cancer Gene Ther. 2023 Apr;30(4):596-607. doi: 10.1038/s41417-022-00574-y. Epub 2022 Dec 9. Cancer Gene Ther. 2023. PMID: 36494581
-
Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine.Genes Dis. 2022 Mar 1;9(6):1443-1465. doi: 10.1016/j.gendis.2021.12.026. eCollection 2022 Nov. Genes Dis. 2022. PMID: 36157483 Free PMC article. Review.
References
-
- Prat J. Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features. Virchows Arch. 2012;460:237–249. - PubMed
-
- Prat J. New insights into ovarian cancer pathology. Ann Oncol. 2012;23:x111–x117. x111-7. - PubMed
-
- Tibiletti MG, Bernasconi B, Furlan D, Bressan P, Cerutti R, Facco C, Franchi M, Riva C, Cinquetti R, Capella C, Taramelli R. Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms. Clin Cancer Res. 2001;7:3404–3409. - PubMed
-
- Lim G, Oliva E. Sex Cord Stromal Tumors of the Ovary. In: Soslow RA, Tornos C, editors. Diagnostic Pathology of Ovarian Tumors. Springer; New York: 2011. pp. 193–234.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials